AbbVie Inc. (ABBV) stock
ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/3090% above fair value
$294.55−0.48 (-0.16%)
Close on Nov 16, 2026Market cap $520.50BP/E 83.2Yield 2.26%
AbbVie operating margin
Operating margin is operating income as a percentage of revenue.
AbbVie's operating margin for the twelve months ending Jun 30, 2026 was 26.2%. For fiscal 2025 it was 24.6%, against 16.2% the year before. The highest annual figure on record is 39.0% in fiscal 2019.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 24.6% | +8.4 |
| FY2024 | Dec 31, 2024 | 16.2% | −7.3 |
| FY2023 | Dec 31, 2023 | 23.5% | −7.7 |
| FY2022 | Dec 31, 2022 | 31.2% | −0.7 |
| FY2021 | Dec 31, 2021 | 31.9% | +7.1 |
| FY2020 | Dec 31, 2020 | 24.8% | −14.2 |
| FY2019 | Dec 31, 2019 | 39.0% | +19.5 |
| FY2018 | Dec 31, 2018 | 19.5% | −14.3 |
| FY2017 | Dec 31, 2017 | 33.8% | −2.6 |
| FY2016 | Dec 31, 2016 | 36.4% | +3.5 |
| FY2015 | Dec 31, 2015 | 33.0% | +15.9 |
| FY2014 | Dec 31, 2014 | 17.1% | −13.1 |
| FY2013 | Dec 31, 2013 | 30.1% | −1.5 |
| FY2012 | Dec 31, 2012 | 31.6% | +10.9 |
| FY2011 | Dec 31, 2011 | 20.8% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 37.9% | +6.1 |
| Q1 FY2026 | Mar 31, 2026 | 26.6% | −1.4 |
| Q4 FY2025 | Dec 31, 2025 | 27.3% | +37.2 |
| Q3 FY2025 | Sep 30, 2025 | 12.1% | −14.4 |
| Q2 FY2025 | Jun 30, 2025 | 31.7% | +4.1 |
| Q1 FY2025 | Mar 31, 2025 | 28.0% | +5.2 |
| Q4 FY2024 | Dec 31, 2024 | -9.9% | −32.2 |
| Q3 FY2024 | Sep 30, 2024 | 26.5% | +10.1 |
| Q2 FY2024 | Jun 30, 2024 | 27.6% | −4.9 |
| Q1 FY2024 | Mar 31, 2024 | 22.7% | +0.1 |
| Q4 FY2023 | Dec 31, 2023 | 22.3% | −14.0 |
| Q3 FY2023 | Sep 30, 2023 | 16.4% | −14.7 |
| Q2 FY2023 | Jun 30, 2023 | 32.5% | +10.0 |
| Q1 FY2023 | Mar 31, 2023 | 22.6% | −12.2 |
| Q4 FY2022 | Dec 31, 2022 | 36.4% | +2.3 |
| Q3 FY2022 | Sep 30, 2022 | 31.1% | +1.1 |
| Q2 FY2022 | Jun 30, 2022 | 22.6% | −9.2 |
| Q1 FY2022 | Mar 31, 2022 | 34.8% | +3.3 |
| Q4 FY2021 | Dec 31, 2021 | 34.1% | +7.0 |
| Q3 FY2021 | Sep 30, 2021 | 30.0% | +4.8 |
| Q2 FY2021 | Jun 30, 2021 | 31.8% | +24.6 |
| Q1 FY2021 | Mar 31, 2021 | 31.5% | −10.3 |
| Q4 FY2020 | Dec 31, 2020 | 27.1% | −18.4 |
| Q3 FY2020 | Sep 30, 2020 | 25.2% | −5.6 |
| Q2 FY2020 | Jun 30, 2020 | 7.2% | −34.0 |
| Q1 FY2020 | Mar 31, 2020 | 41.8% | +3.4 |
| Q4 FY2019 | Dec 31, 2019 | 45.5% | +74.8 |
| Q3 FY2019 | Sep 30, 2019 | 30.9% | −7.5 |
| Q2 FY2019 | Jun 30, 2019 | 41.2% | +7.8 |
| Q1 FY2019 | Mar 31, 2019 | 38.5% | +1.9 |
| Q4 FY2018 | Dec 31, 2018 | -29.4% | −52.4 |
| Q3 FY2018 | Sep 30, 2018 | 38.4% | −0.2 |
| Q2 FY2018 | Jun 30, 2018 | 33.4% | −5.0 |
| Q1 FY2018 | Mar 31, 2018 | 36.6% | −0.2 |
| Q4 FY2017 | Dec 31, 2017 | 23.0% | −11.0 |
| Q3 FY2017 | Sep 30, 2017 | 38.5% | +1.8 |
| Q2 FY2017 | Jun 30, 2017 | 38.3% | – |
| Q1 FY2017 | Mar 31, 2017 | 36.8% | – |
| Q4 FY2016 | Dec 31, 2016 | 34.0% | – |
| Q3 FY2016 | Sep 30, 2016 | 36.7% | – |
See a number that looks wrong?